Latest filing published 19 May 2021 for TFF Pharmaceuticals, Inc., €74k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Malcolm Fairbairn: trading record in brief
This profile gathers the share dealings of Malcolm Fairbairn in TFF Pharmaceuticals, Inc., where the filings describe the role as board member. In total, 3 filings cover trades dated from 11 November 2020 to 19 May 2021.
On the open market, the record shows 1 purchase worth €74k and 2 sales worth €1.0M. Sales outweigh purchases by €938k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2021, the count stands at 1 purchase and no sales.
The record was last updated on 19 May 2021 with an open-market purchase (€74k) in TFF Pharmaceuticals, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Malcolm Fairbairn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$8.95100.0% of flowCommon StockSEC:0001213900-21-027900:0Canonical exit: 17 Aug 2021 (T+90)
- 63,331 shares@ US$15.93178.7% of flowCommon StockSEC:0001213900-20-037062:0
- 11,669 shares@ US$15.96614.6% of flowCommon StockSEC:0001213900-20-037062:1
3 of 3 declarations